Outsourcing vs In-House Respiratory Research: Which Approach Is Right for Preclinical Drug Development?

Outsourcing vs In-House Respiratory Research: Which Approach Is Right for Preclinical Drug Development?

by Virtus | Apr 11, 2026 | Early-Stage Respiratory Drug Development

Outsourcing vs in-house respiratory research is a common consideration for biotech and pharmaceutical companies developing therapies for asthma, COPD, and viral respiratory diseases. Respiratory drug development requires specialised preclinical models, in vivo...
Viral Challenge Preclinical Studies in Respiratory Drug Development

Viral Challenge Preclinical Studies in Respiratory Drug Development

by Virtus | Apr 11, 2026 | Viral & Rhinovirus Models

Viral challenge preclinical studies are used in respiratory preclinical research to evaluate how therapeutic candidates perform under controlled viral infection conditions. These studies are commonly applied in respiratory drug development to investigate antiviral...
Respiratory CRO in the UK: How to Evaluate Preclinical Respiratory Research Partners

Respiratory CRO in the UK: How to Evaluate Preclinical Respiratory Research Partners

by Virtus | Apr 11, 2026 | Early-Stage Respiratory Drug Development

Finding the best respiratory CRO in the UK is a key step for biotech and pharmaceutical companies developing therapies for asthma, COPD, and viral respiratory diseases. Respiratory drug development requires specialised preclinical models, in vivo respiratory studies,...
Asthma vs COPD Preclinical Models in Respiratory Drug Development

Asthma vs COPD Preclinical Models in Respiratory Drug Development

by Virtus | Mar 21, 2026 | Respiratory Preclinical Research

Asthma vs COPD preclinical models are frequently compared in respiratory preclinical research because both disease areas require distinct experimental systems to evaluate therapeutic efficacy. While asthma preclinical models focus on immune-mediated airway...
Respiratory CRO in the UK: How to Evaluate Preclinical Respiratory Research Partners

How to Choose a Respiratory Preclinical CRO in the UK

by Virtus | Mar 21, 2026 | Early-Stage Respiratory Drug Development

Selecting a respiratory preclinical CRO in the UK is a key decision in early stage respiratory drug development. Respiratory diseases such as asthma, COPD, and viral respiratory infections require disease-specific preclinical models, in vivo respiratory studies, and...
« Older Entries
Next Entries »

Recent Posts

  • Preclinical COPD Models: Choosing the Right Approach for Drug Development
  • Bronchoalveolar Lavage in Preclinical Respiratory Research
  • In Vitro Respiratory Disease Models: Applications in Preclinical Drug Discovery
  • Preclinical Respiratory Efficacy Studies: Choosing the Right Models, Endpoints and Research Approach
  • Airway Hyperresponsiveness Models in Preclinical Asthma Research

Recent Comments

No comments to show.

Privacy Notice and Cookie Policy





All content © 2022 Virtus Respiratory Research. All Rights Reserved.

Contact